Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population
Nutrition, Metabolism and Cardiovascular Diseases · 2025
DOI: 10.1016/j.numecd.2025.104029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Pingfeng Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, Nanfang Hospital Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Peptide Fragments, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND AIM: N-terminal pro B-type natriuretic peptide (NT-proBNP) is a key biomarker for assessing cardiac function and hemodynamic stress. However, clinical guidelines lack clear recommendations on its utility in populations at risk of heart failure (HF), including those with hypertension, diabetes, or dyslipidemia. This study aimed to characterize the distribution of NT-proBNP levels in HF-prone individuals and establish population-specific screening thresholds. METHODS AND RESULTS: A cross-sectional analysis was conducted across three cohorts: 2421 patients with HF risk factors (hypertension, diabetes, or dyslipidemia), 625 patients with congestive HF, and 833 healthy controls. NT-proBNP levels were stratified by cardiovascular risk categories based on established guidelines. Receiver operating characteristic (ROC) curves were used to determine optimal screening thresholds. Key findings included. CONCLUSIONS: NT-proBNP levels effectively mirror cardiovascular risk stratification in HF-susceptible populations. Adopting risk-stratified reference values (106.0-116.7 pg/mL vs. 124.6 pg/mL in healthy adults) may enhance early HF detection and personalized risk management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory, Nanfang Hospital Southern Medical University, Guangzhou, 510515, China.
- Medical Laboratory of ShenzhenLuohu Hospital Group, Shenzhen, 518005, China.
- Shenzhen Mindray Bio-Medical Electronics Co.LTD, Shenzhen, 518057, China.
- Department of Medical Laboratory, Nanfang Hospital Southern Medical University, Guangzhou, 510515, China. Electronic address: 766818985@qq.com.
Zitieren
APA
Feng, P., Qin, J., Chai, Z., Wei, D., Zhang, Y., Wang, P., Zhao, M., He, B., Ling, Z., & Li, X. (2025). Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104029
Vancouver
Feng P, Qin J, Chai Z, Wei D, Zhang Y, Wang P, et al. Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104029
BibTeX
@article{Feng2025,
author = {Feng, Pingfeng and Qin, Junlong and Chai, Zhixin and Wei, Dong and Zhang, Yajie and Wang, Peiyun and Zhao, Minghai and He, Bingbing and Ling, Zhongyi and Li, Xin},
title = {Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.numecd.2025.104029}
}
EUVIMED